Main Management ETF Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-612,180
Closed -$78.3M 139
2025
Q1
$78.3M Hold
612,180
3.81% 10
2024
Q4
$80.9M Buy
612,180
+18,810
+3% +$2.49M 3.67% 10
2024
Q3
$86.4M Buy
593,370
+14,535
+3% +$2.12M 4.1% 8
2024
Q2
$79.5M Buy
578,835
+14,535
+3% +$2M 3.97% 9
2024
Q1
$77.4M Buy
564,300
+18,810
+3% +$2.58M 4.09% 10
2023
Q4
$74.1M Buy
+545,490
New +$74.1M 4.35% 9
2022
Q4
Sell
-177,480
Closed -$20.8M 35
2022
Q3
$20.8M Buy
177,480
+1,440
+0.8% +$168K 2.38% 15
2022
Q2
$20.7M Sell
176,040
-360
-0.2% -$42.3K 2.3% 14
2022
Q1
$23M Buy
176,400
+1,080
+0.6% +$141K 2.14% 14
2021
Q4
$26.8M Buy
175,320
+9,000
+5% +$1.37M 2.35% 14
2021
Q3
$26.9M Buy
166,320
+7,560
+5% +$1.22M 2.72% 14
2021
Q2
$26M Buy
158,760
+8,280
+6% +$1.36M 2.71% 14
2021
Q1
$22.7M Buy
150,480
+28,050
+23% +$4.22M 2.68% 14
2020
Q4
$18.5M Sell
122,430
-330
-0.3% -$50K 2.9% 14
2020
Q3
$16.6M Sell
122,760
-3,300
-3% -$447K 2.93% 13
2020
Q2
$17.2M Buy
126,060
+5,610
+5% +$767K 3.25% 12
2020
Q1
$13M Sell
120,450
-330
-0.3% -$35.6K 3.1% 11
2019
Q4
$14.6M Buy
120,780
+5,280
+5% +$636K 2.82% 12
2019
Q3
$11.5M Sell
115,500
-84,300
-42% -$8.39M 2.5% 12
2019
Q2
$21.8M Buy
199,800
+12,000
+6% +$1.31M 5.02% 10
2019
Q1
$21M Buy
187,800
+10,200
+6% +$1.14M 4.87% 10
2018
Q4
$17.1M Buy
177,600
+10,200
+6% +$984K 4.79% 9
2018
Q3
$20.4M Buy
167,400
+19,800
+13% +$2.41M 5.14% 8
2018
Q2
$16.2M Buy
147,600
+22,200
+18% +$2.44M 4.83% 9
2018
Q1
$13.4M Buy
125,400
+20,400
+19% +$2.18M 4.74% 10
2017
Q4
$11.2M Buy
+105,000
New +$11.2M 4.79% 9